世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界のコルチコステロイド外用薬市場 2018-2022年

Global Topical Corticosteroids Market 2018-2022

IRTNTR23935

 

出版社 出版年月電子版価格 ページ数
TechNavio
テクナビオ
2018年10月US$2,500
シングルユーザライセンス
110

サマリー

この調査レポートは世界のコルチコステロイド外用薬市場を分析・予測したTechNavioの市場調査報告書です。

Description

About Topical Corticosteroids
Corticosteroids are hormones produced by the adrenal glands within the body. Topical corticosteroids are synthetic corticosteroids that are used for the treatment of skin-related diseases such as psoriasis, eczema, dermatitis, and itching.
Technavio’s analysts forecast the Global Topical Corticosteroids Market to grow at a CAGR of 5.94% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the topical corticosteroids market. To calculate the market size, the report considers the revenue generated from the retail sales of topical corticosteroids across the globe.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, topical corticosteroids market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- GlaxoSmithKline
- LEO Pharma
- Merck Sharp & Dohme
- Novartis
- Pfizer
Market driver
- Increasing prevalence of skin disorders
- For a full, detailed list, view our report

Market challenge
- Highly fragmented market
- For a full, detailed list, view our report

Market trend
- Growing customer preference for topical delivery
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.



目次

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: PIPELINE LANDSCAPE
- Drugs under development
PART 08: MARKET SEGMENTATION BY PRODUCT
- Segmentation by product
- Comparison by product
- Prescription - Market size and forecast 2017-2022
- OTC - Market size and forecast 2017-2022
- Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas - Market size and forecast 2017-2022
- EMEA - Market size and forecast 2017-2022
- APAC - Market size and forecast 2017-2022
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 13: MARKET TRENDS
- Customer preference for topical delivery
- Use of different bases in topical drug delivery
- Development of silicones for topical and transdermal drug delivery
PART 14: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 15: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- GlaxoSmithKline
- LEO Pharma
- Merck Sharp & Dohme
- Novartis
- Pfizer
PART 16: APPENDIX
- List of abbreviations


-
-
Exhibit 01: Parent market
Exhibit 02: Global topical drugs market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global topical corticosteroids market - Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global topical corticosteroids market - Year-over-year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Topical corticosteroids pipeline landscape
Exhibit 19: Molecules in the pipeline
Exhibit 20: Global topical corticosteroids market by product? Market share 2017-2022 (%)
Exhibit 21: Comparison by product
Exhibit 22: Prescription - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Prescription - Year-over-year growth 2018-2022 (%)
Exhibit 24: OTC - Market size and forecast 2017-2022 ($ mn)
Exhibit 25: OTC - Year-over-year growth 2018-2022 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Customer landscape
Exhibit 28: Global topical corticosteroids market by geography - Market share 2017-2022 (%)
Exhibit 29: Regional comparison
Exhibit 30: Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Americas - Year-over-year growth 2018-2022 (%)
Exhibit 32: Top 3 countries in Americas
Exhibit 33: EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 34: EMEA - Year-over-year growth 2018-2022 (%)
Exhibit 35: Top 3 countries in EMEA
Exhibit 36: APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 37: APAC - Year-over-year growth 2018-2022 (%)
Exhibit 38: Top 3 countries in APAC
Exhibit 39: Market opportunity
Exhibit 40: Population index 2000-2017
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: GlaxoSmithKline: Overview
Exhibit 47: GlaxoSmithKline - Business segments
Exhibit 48: GlaxoSmithKline - Organizational development
Exhibit 49: GlaxoSmithKline - Geographic focus
Exhibit 50: GlaxoSmithKline - Segment focus
Exhibit 51: GlaxoSmithKline - Key offerings
Exhibit 52: LEO Pharma: Overview
Exhibit 53: LEO Pharma - Business segments
Exhibit 54: LEO Pharma - Organizational developments
Exhibit 55: LEO Pharma - Geographic focus
Exhibit 56: LEO Pharma - Segment focus
Exhibit 57: LEO Pharma - Key offerings
Exhibit 58: LEO Pharma - Key customers
Exhibit 59: Merck Sharp & Dohme: Overview
Exhibit 60: Merck Sharp & Dohme - Business segments
Exhibit 61: Merck Sharp & Dohme - Organizational developments
Exhibit 62: Merck Sharp & Dohme - Geographic focus
Exhibit 63: Merck Sharp & Dohme - Segment focus
Exhibit 64: Merck Sharp & Dohme - Key offerings
Exhibit 65: Merck Sharp & Dohme - Key customers
Exhibit 66: Novartis: Overview
Exhibit 67: Novartis - Business segments
Exhibit 68: Novartis - Organizational developments
Exhibit 69: Novartis - Geographic focus
Exhibit 70: Novartis - Segment focus
Exhibit 71: Novartis - Key offerings
Exhibit 72: Novartis - Key customers
Exhibit 73: Pfizer: Overview
Exhibit 74: Pfizer - Business segments
Exhibit 75: Pfizer - Organizational developments
Exhibit 76: Pfizer - Geographic focus
Exhibit 77: Pfizer - Segment focus
Exhibit 78: Pfizer - Key offerings
Exhibit 79: Pfizer - Key customers


 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る